You Are Here: Home » Fairfield » Conn. to receive share of GSK settlement

Conn. to receive share of GSK settlement

Connecticut will receive nearly $1.7 million as part of a $90 million, multi-state settlement with drug maker GlaxoSmithKline Plc over deceptive marketing practices, state Attorney General George Jepsen announced Nov. 15.

The settlement resolves allegations that the global pharmaceutical company engaged in deceptive marketing practices by misrepresenting the cardiovascular risks of its diabetes drug Avandia.

In addition to Connecticut, 37 other states participated in the settlement agreement.

The payout comes after Connecticut joined a $3 billion settlement between GSK and both the federal government and state governments over claims that the company engaged in illegal marketing practices relating to several drugs it manufactures, including Paxil, Wellbutrin and Avandia.


About The Author

Patrick Gallagher

Bio: Fairfield County Bureau Chief Staff Reporter Westchester County Business Journal Covers: Economy, energy, government, infrastructure and public works projects, law, media, technology Phone: (914) 694-3600, ext. 3017

Number of Entries : 855

Leave a Comment

Copyright Westfair Business Publications • All rights reserved • Reproduction in whole , or in part, without written permission is strictly prohibited
Westfair Communications Inc. • 3 Gannett Drive, Suite G7 • White Plains, NY 10604-3407 • Tel: (914) 694-3600
Scroll to top